Lysyl oxidase inhibition via β-aminoproprionitrile hampers human umbilical vein endothelial cell angiogenesis and migration in vitro

Shi,Lin; Zhang,Ning; Liu,Hetao; Zhao,Lei; Liu,Jing; Wan,Juan; Wu,Wenyi; Lei,Hetian; Liu,Rongqing; Han,Mei

doi:10.3892/mmr.2018.8508

April-2018 Volume 17 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

April-2018 Volume 17 Issue 4

Full Size Image

Article Open Access

Lysyl oxidase inhibition via β-aminoproprionitrile hampers human umbilical vein endothelial cell angiogenesis and migration in vitro

Authors:
- Lin Shi
- Ning Zhang
- Hetao Liu
- Lei Zhao
- Jing Liu
- Juan Wan
- Wenyi Wu
- Hetian Lei
- Rongqing Liu
- Mei Han
View Affiliations / Copyright

Affiliations: Department of Pathogenic Biology and Immunology, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China, Department of Rheumatology and Immunology, The General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China, Schepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA 02114, USA

Copyright: © Shi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Pages: 5029-5036
|
Published online on: January 26, 2018

https://doi.org/10.3892/mmr.2018.8508
Expand metrics +

Abstract

Lysyl oxidase (LOX) is an enzyme that oxidizes lysine residues in collagens and elastin. It stabilizes or remodels the extracellular matrix and basement membrane of blood vessels. Current oncology studies have revealed that LOX is upregulated in invasive cancer cells and bolstered cell movement, and LOX was observed to promote the angiogenesis and migration of endothelial cells. In the present study, angiogenesis and migration were examined in human umbilical vein endothelial cells (HUVECs). Following cell treatment with 0.1-0.4 mM β-aminoproprionitrile (BAPN), a specific inhibitor of LOX, angiogenesis was analyzed with a fibrin gel in vitro angiogenesis assay kit and migration was examined via a Boyden Chamber assay. Angiogenesis-associated gene expression was investigated with a microarray assay and confirmed with reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The results showed that HUVEC angiogenesis substantially increased in the presence of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and phorbol 12-myristate 13-acetate (PMA). In addition, LOX inhibition blocked the angiogenesis stimulated by VEGF bFGF and PMA, and the inhibition of LOX reduced the migration of HUVECs. Furthermore, the microarray and RT-qPCR revealed that BAPN downregulated myeloid progenitor inhibitory factor 1, and western blot analysis demonstrated that BAPN decreased the phosphorylation of MAPK and Akt, suggesting that the specific inhibitor of LOX, BAPN, may serve as an alternative strategy for preventing angiogenesis.

View Figures

View References

1	Wong VW and Crawford JD: Vasculogenic cytokines in wound healing. Biomed Res Int. 2013:1904862013. View Article : Google Scholar : PubMed/NCBI
2	Moon JJ, Saik JE, Poché RA, Leslie-Barbick JE, Lee SH, Smith AA, Dickinson ME and West JL: Biomimetic hydrogels with pro-angiogenic properties. Biomaterials. 31:3840–3847. 2010. View Article : Google Scholar : PubMed/NCBI
3	Eelen G, de Zeeuw P, Simons M and Carmeliet P: Endothelial cell metabolism in normal and diseased vasculature. Circ Res. 116:1231–1244. 2015. View Article : Google Scholar : PubMed/NCBI
4	Hoang S, Liauw J, Choi M, Choi M, Guzman RG and Steinberg GK: Netrin-4 enhances angiogenesis and neurologic outcome after cerebral ischemia. J Cereb Blood Flow Metab. 29:385–397. 2009. View Article : Google Scholar : PubMed/NCBI
5	Weis SM and Cheresh DA: Tumor angiogenesis: Molecular pathways and therapeutic targets. Nat Med. 17:1359–1370. 2011. View Article : Google Scholar : PubMed/NCBI
6	Gibofsky A: Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care. 18 13 Suppl:S295–S302. 2012.PubMed/NCBI
7	Wang CX and Shuaib A: Critical role of microvasculature basal lamina in ischemic brain injury. Prog Neurobiol. 83:140–148. 2007. View Article : Google Scholar : PubMed/NCBI
8	Gautam J, Zhang X and Yao Y: The role of pericytic laminin in blood brain barrier integrity maintenance. Sci Rep. 6:364502016. View Article : Google Scholar : PubMed/NCBI
9	Knapton AD, Zhang J, Sistare FD and Hanig JP: The use of in situ perfusion of the rat mesentery as a model to investigate vascular injury directly induced by drugs. Methods Find Exp Clin Pharmacol. 32:489–497. 2010. View Article : Google Scholar : PubMed/NCBI
10	Kagan HM and Li W: Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem. 88:660–672. 2003. View Article : Google Scholar : PubMed/NCBI
11	Mäki JM: Lysyl oxidases in mammalian development and certain pathological conditions. Histol Histopathol. 24:651–660. 2009.PubMed/NCBI
12	Erez N: Cancer: Opening LOX to metastasis. Nature. 522:41–42. 2015. View Article : Google Scholar : PubMed/NCBI
13	Perryman L and Erler JT: Lysyl oxidase in cancer research. Future Oncol. 10:1709–1717. 2014. View Article : Google Scholar : PubMed/NCBI
14	Rodríguez C, Rodríguez-Sinovas A and Martínez-González J: Lysyl oxidase as a potential therapeutic target. Drug News Perspect. 21:218–224. 2008. View Article : Google Scholar : PubMed/NCBI
15	Osawa T, Ohga N, Akiyama K, Hida Y, Kitayama K, Kawamoto T, Yamamoto K, Maishi N, Kondoh M, Onodera Y, et al: Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis. Br J Cancer. 109:2237–2247. 2013. View Article : Google Scholar : PubMed/NCBI
16	Mammoto T, Jiang A, Jiang E, Panigrahy D, Kieran MW and Mammoto A: Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression. Am J Pathol. 183:1293–1305. 2013. View Article : Google Scholar : PubMed/NCBI
17	Wang F, Wan J, Li Q, Zhang M, Wan Q, Ji C, Li H, Liu R and Han M: Lysyl oxidase is involved in synovial hyperplasia and angiogenesis in rats with collagen-induced arthritis. Mol Med Rep. 16:6736–6742. 2017. View Article : Google Scholar : PubMed/NCBI
18	Sharma-Bhandari A, Park SH, Kim JY, Oh J and Kim Y: Lysyl oxidase modulates the osteoblast differentiation of primary mouse calvaria cells. Int J Mol Med. 36:1664–1670. 2015. View Article : Google Scholar : PubMed/NCBI
19	Yin KJ, Hamblin M and Chen YE: Angiogenesis-regulating microRNAs and ischemic stroke. Curr Vasc Pharmacol. 13:352–365. 2015. View Article : Google Scholar : PubMed/NCBI
20	Liu N, Zhang Y, Fan L, Yuan M, Du H, Cheng R, Liu D and Lin F: Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats. J Transl Med. 9:1052011. View Article : Google Scholar : PubMed/NCBI
21	Aciksari K, Yanar HT, Hepgul G, Ozucelik DN, Yanar F, Agcaoglu O, Eser M, Tanriverdi G, Topacoglu H, Ayvaci BM, et al: The effect of Beta-aminopropionitrile and prednisolone on the prevention of fibrosis in alkali esophageal burns: An experimental study. Gastroenterol Res Pract. 2013:5742602013. View Article : Google Scholar : PubMed/NCBI
22	Miana M, Galán M, Martínez-Martínez E, Varona S, Jurado-López R, Bausa-Miranda B, Antequera A, Luaces M, Martínez-González J, Rodríguez C and Cachofeiro V: The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats. Dis Model Mech. 8:543–551. 2015. View Article : Google Scholar : PubMed/NCBI
23	Shibuya M: Vascular endothelial growth factor and its receptor system: Physiological functions in angiogenesis and pathological roles in various diseases. J Biochem. 153:13–19. 2013. View Article : Google Scholar : PubMed/NCBI
24	Li R, Wu H, Xie J, Li G, Gu R, Kang L, Wang L and Xu B: Syndecan-4 regulates the bFGF-induced chemotactic migration of endothelial cells. J Mol Histol. 47:503–509. 2016. View Article : Google Scholar : PubMed/NCBI
25	Fus ŁP and Górnicka B: Role of angiogenesis in urothelial bladder carcinoma. Cent European J Urol. 69:258–263. 2016.PubMed/NCBI
26	Padma D and Bhat KM: A comparison between phorbol 12 myristate 13 acetate and phorbol 12, 13 dibutyrate in human melanocyte culture. J Clin Diagn Res. 10:GC01–GC04. 2016.PubMed/NCBI
27	Patel VP, Kreider BL, Li Y, Li H, Leung K, Salcedo T, Nardelli B, Pippalla V, Gentz S, Thotakura R, et al: Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors. J Exp Med. 185:1163–1172. 1997. View Article : Google Scholar : PubMed/NCBI
28	Youn BS, Zhang SM, Broxmeyer HE, Cooper S, Antol K, Fraser M Jr and Kwon BS: Characterization of CKbeta8 and CKbeta8-1: Two alternatively spliced forms of human beta-chemokine, chemoattractants for neutrophils, monocytes, and lymphocytes, and potent agonists at CC chemokine receptor 1. Blood. 91:3118–3126. 1998.PubMed/NCBI
29	Hwang J, Son KN, Kim CW, Ko J, Na DS, Kwon BS, Gho YS and Kim J: Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis. Cytokine. 30:254–263. 2005. View Article : Google Scholar : PubMed/NCBI
30	Poposki JA, Uzzaman A, Nagarkar DR, Chustz RT, Peters AT, Suh LA, Carter R, Norton J, Harris KE, Grammer LC, et al: Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 128:73–81.e4. 2011. View Article : Google Scholar : PubMed/NCBI
31	Kim J, Kim YS and Ko J: CK beta 8/CCL23 induces cell migration via the Gi/Go protein/PLC/PKC delta/NF-kappa B and is involved in inflammatory responses. Life Sci. 86:300–308. 2010. View Article : Google Scholar : PubMed/NCBI
32	Das AM, Pescatori M, Vermeulen CE, Rens JA, Seynhaeve AL, Koning GA, Eggermont AM and Ten Hagen TL: Melanomas prevent endothelial cell death under restrictive culture conditions by signaling through AKT and p38 MAPK/ERK-1/2 cascades. Oncoimmunology. 5:e12198262016. View Article : Google Scholar : PubMed/NCBI